$15.87
-0.67-4.05%
At close: Nov 11, 4:00 PM EST
$15.99
-0.55-3.33%
Pre-Market: 4:02 AM EST
Jade Biosciences Inc (JBIO) Stock Price, Quote, News & History
JBIONASDAQ
Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.
You can purchase shares of Jade Biosciences (NASDAQ:JBIO) through any online brokerage.
Other companies in Jade Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Jade Biosciences has a consensus price target of $46.83.
The stock price for Jade Biosciences (NASDAQ: JBIO) is $15.99 last updated November 13, 2026 at 7:00 AM EST.
There are no upcoming dividends for Jade Biosciences.
Jade Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Jade Biosciences.
Jade Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin...
